BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3698228)

  • 1. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.
    Monrad ES; Matsumori A; Murphy JC; Fox JG; Crumpacker CS; Abelmann WH
    Circulation; 1986 May; 73(5):1058-64. PubMed ID: 3698228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus.
    Matsumori A; Kawai C
    Circulation; 1982 Aug; 66(2):355-60. PubMed ID: 6212162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil ameliorates the clinical and pathological course of murine myocarditis.
    Dong R; Liu P; Wee L; Butany J; Sole MJ
    J Clin Invest; 1992 Nov; 90(5):2022-30. PubMed ID: 1331179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral myocarditis: immunopathogenesis and the effect of immunosuppressive treatment in a murine model.
    Matsumori A; Tomioka N; Kawai C
    Jpn Circ J; 1989 Jan; 53(1):58-60. PubMed ID: 2541264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of viral myocarditis with ribavirin in an animal preparation.
    Matsumori A; Wang H; Abelmann WH; Crumpacker CS
    Circulation; 1985 Apr; 71(4):834-9. PubMed ID: 2982522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis.
    Iwasaki A; Matsumori A; Yamada T; Shioi T; Wang W; Ono K; Nishio R; Okada M; Sasayama S
    J Am Coll Cardiol; 1999 Apr; 33(5):1400-7. PubMed ID: 10193745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalomyocarditis (EMC) virus myocarditis in DBA/2 mice. I. Acute stage.
    Matsumori A; Kawai C; Sawada S
    Jpn Circ J; 1981 Dec; 45(12):1403-8. PubMed ID: 6275136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
    Tanaka A; Matsumori A; Wang W; Sasayama S
    Circulation; 1994 Oct; 90(4):2051-5. PubMed ID: 7923693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.
    Matsumori A; Kawai C
    Circulation; 1982 Jun; 65(6):1230-5. PubMed ID: 6280889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from animal experiments in myocarditis.
    Matsumori A
    Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model.
    Matsumori A; Crumpacker CS; Abelmann WH
    J Am Coll Cardiol; 1987 Jun; 9(6):1320-5. PubMed ID: 3034992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cyclosporine on the immunopathogenesis of viral myocarditis in mice.
    Matoba Y; Matsumori A; Okada I; Ohkusa T; Kawai C
    Jpn Circ J; 1991 Apr; 55(4):407-16. PubMed ID: 1646340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on effect of xinkang oral liquid on coxsackie B3 viral myocarditis in mice].
    Zhao H; Wan SJ; Xu XL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):277-9. PubMed ID: 12577357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
    Kishimoto C; Abelmann WH
    Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbred mice infected by an encephalomyocarditis virus variant: a model for studying chronic viral heart disease.
    Kruppenbacher JP; Arnold G; Mertens T; Fischer A; Zimmermann J; Eggers HJ
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):405-13. PubMed ID: 8391736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Thorp KA; Abelmann WH
    Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephalomyocarditis virus myocarditis in inbred strains of mice--chronic stage.
    Matsumori A; Kawai C; Sawada S
    Jpn Circ J; 1982 Nov; 46(11):1192-6. PubMed ID: 6290692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
    Okada I; Matsumori A; Tomioka N; Kawai C
    J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.
    Ito H; Ono K; Nishio R; Sasayama S; Matsumori A
    Cytokine; 2002 Feb; 17(4):197-202. PubMed ID: 11991672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditis.
    Kishimoto C; Takada H; Hiraoka Y; Kurokawa M; Ochiai H
    Heart Vessels; 1997; 12(2):67-73. PubMed ID: 9403310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.